We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.
- Authors
Martinelli, Giovanni; Laszlo, Daniele; Ferreri, Andrés J M; Pruneri, Giancarlo; Ponzoni, Maurilio; Conconi, Annarita; Crosta, Cristiano; Pedrinis, Ennio; Bertoni, Francesco; Calabrese, Liliana; Zucca, Emanuele
- Abstract
Preliminary results using rituximab in extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients seem to indicate a relevant clinical activity. Aim of the present study is to investigate the efficacy of conventional weekly treatment using rituximab in gastric MALT NHL patients resistant/refractory or not suitable for eradication treatment, and to evaluate the relevance of the t(11; 18)(q21; q21) translocation and its possible role as a predictive criteria of response.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 9, p1979
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.08.128